New approach in asthma treatment using excitatory modulator

Phytotherapy Research

Volumn 21, Issue 6, 2007, Pages 554-557

  Hoang, Ba X ^a   Shaw, D Graeme ^b   Levine, Stephen ^c   Hoang, Cuong ^d   Pham, Phuong ^e  

^a Allergy Research Group   (United States)

^b Advanced Integrative Medicine   (United States)

^c Allergy Research Group   (United States)

^d Institute os Ophthalmology   (Viet Nam)

^e UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Asthma treatment; Sophora flavescens

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; SOPHORA FLAVESCENS EXTRACT;

ADULT; AGED; ALTERNATIVE MEDICINE; ARTICLE; ASTHMA; CLINICAL ARTICLE; CONTROLLED STUDY; DIARRHEA; DRUG MECHANISM; DRUG MEGADOSE; DRUG USE; FEMALE; FOLLOW UP; HUMAN; INFORMED CONSENT; MALE; PLANT ROOT; QUALITY OF LIFE; RESPIRATORY FUNCTION;

ADULT; AGED; ANTI-ASTHMATIC AGENTS; ASTHMA; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FABACEAE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; PHYTOTHERAPY; PLANT EXTRACTS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

SOPHORA FLAVESCENS;

EID: 34250341193     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.2107     Document Type: Article

References (29)

1. Chen X, Yi C, Yang X, Wang X. 2004. Liquid chromatography of active principles in Sophora flavescens root. J Chromatogr B Analyt Technol Biomed Life Sci 812: 149-163.
2. Dawson VL, Dawson TM, Bartley DA, Uhl GR, Snyder SH. 1993. Mechanisms of nitric oxide-mediated neurotoxicity in primary brain cultures. J Neurosci 13: 2651-2661.
3. Decco ML, Neeno TA, Hunt LW, O'Connell EJ, Yunginger JW, Sachs MI. 1999. Nebulized lidocaine in the treatment of severe asthma in children: a pilot study. Ann Allergy Asthma Immunol 82: 29-32.
4. Dickman KG, Youssef JG, Mathew SM, Said SI. 2004. Ionotropic glutamate receptors in lungs and airways: molecular basis for glutamate toxicity. Am J Respir Cell Mol Biol 30: 139-144.
5. Haxhiu MA, Chavez JC, Pichiule P, Erokwu B, Dreshaj IA. 2000. The excitatory amino acid glutamate mediates reflexly increased tracheal blood flow and airway submucosal gland secretion. Brain Res 883: 77-86.
6. Hunt LW, Frigas E, Butterfield JH et al. 2004. Treatment of asthma with nebulized lidocaine: a randomized, placebo-controlled study. J Allergy Clin Immunol 113: 853-859.
7. Hunt LW, Swedlund HA, Gleich GJ. 1996. Effect of nebulized lidocaine on severe glucocorticoid-dependent asthma. Mayo Clin Proc 71: 361-368.
8. Ishida M, Shinozaki H. 1984. Glutamate inhibitory action of matrine at the crayfish neuromuscular junction. Br J Pharmacol 82: 523-531.
9. Jain S, Jain KC. 1991. Effect of phenytoin sodium in the management of poorly controlled bronchial asthma at a rural health center in Phalodi, Rajasthan, India. J Asthma 28: 201-211.
10. Jarjour N, McGill K, Busse WW, Gelfand E. 1996. Alternative anti-inflammatory and immunomodulatory therapy. In Lung Biology in Health and Disease Severe Asthma: Pathogenesis and Clinical Management, Szefler SJ, Leung DYM (eds), vol. 86. Marcel Dekker: New York, 333-339.
11. Lin DZ, Fang YS. 1990. Modern Study and Application of Materia Medica. China Ocean Press: Beijing.
12. Liu M, Liu XY, Cheng JF. 2003. (Advance in the pharmacological research on matrine). Zhongguo Zhong Yao Za Zhi 28: 801-804.
13. McGeehan M, Busse WW. 2002. Refractory asthma. Med Clin North Am 86: 1073-1090.
14. Pharmacopoeia of the People's Republic of China. 2000. Chemical Industry Press: Beijing.
15. Said SI. 1999. Glutamate receptors and asthmatic airway disease. Trends Pharmacol Sci 20: 132-134.
16. Said SI, Berisha HI, Pakbaz H. 1996. Excitotoxicity in the lung: N-methyl-D-aspartate-induced, nitric oxide-dependent, pulmonary edema is attenuated by vasoactive intestinal peptide and by inhibitors of poly(ADP-ribose) polymerase. Proc Natl Acad Sci USA 93: 4688-4692.
17. Sayar B, Polvan O. 1968. Epilepsy and bronchial asthma. Lancet 1(7550): 1038.
18. Shah JR, Vora G, Karkhanis AV, Talwalkar CV. 1970. The effect of diphenylhydantoin on ventilation tests in airway obstruction. Indian J Chest Dis 12: 10-14.
19. Shulman MH. 1942. The use of dilantin sodium in bronchial asthma: a preliminary report. N Engl J Med 226: 260-264.
20. Spector SL. 1997. Treatment of the unusually difficult asthmatic patient. Allergy Asthma Proc 18: 153-155.
21. Tang W, Eisenbrand G. 1992. Chinese Drugs of Plant Origin. Springer-Verlag: Berlin.
22. Walker S, Monteil M, Phelan K, Lasserson TJ, Walters EH. 2004. Anti-IgE for chronic asthma in adults and children. Cochrane Database Syst Rev 2004(3): CD003559.
23. Wen MC, Wei CH, Hu ZQ et al. 2005. Efficacy and tolerability of anti-asthma herbal medicine intervention in adult patients with moderate-severe allergic asthma. J Allergy Clin Immunol 116: 517-524.
24. Wenzel S. 2003. Mechanisms of severe asthma. Clin Exp Allergy 33: 1622-1628.
25. Yamazaki M. 2000. (The pharmacological studies on matrine and oxymatrine). Yakugaku Zasshi 120: 1025-1033.
26. Yamazaki M, Arai A, Suzuki S, Takeuchi T. 1984. [Protective effects of matrine and oxymatrine on stress ulcer in relation to their effects on the central nervous system]. Yakugaku Zasshi 104: 293-301.
27. Yu HQ, Wang PX, Liu L, Liu FJ, Liu MP. 1999. Kushen. In Immuno-herbology of Traditional Chinese Medicine: Immunology, Pharmacology and Clinic, Luo HS, Luo DH (eds). Beijing Medical University and Chinese Academy of Medical Sciences and Peking Union Medical College Union Publisher: Beijing, 208-213.
28. Zhang HM, Li HQ. 1999. Anti-arrhythmic effects of sophoridine and oxysophoridine. Zhongguo Yao Li Xue Bao 20: 517-520.
29. Zhang BH, Wang NS, Li XJ, Kong XJ, Cai YL. 1990. [Antiarrhythmic effects of matrine]. Zhongguo Yao Li Xue Bao 11: 253-257.